# Study to Investigate the Effects of Food on Relative Bioavailability of ABP-671 Tablets in Healthy Subjects

> **NCT04303039** · PHASE1 · COMPLETED · sponsor: **Atom Therapeutics Co., Ltd** · enrollment: 12 (actual)

## Conditions studied

- Gout
- Food-drug Interaction

## Interventions

- **DRUG:** ABP-671

## Key facts

- **NCT ID:** NCT04303039
- **Lead sponsor:** Atom Therapeutics Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-05-22
- **Primary completion:** 2020-06-09
- **Final completion:** 2020-06-19
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2020-06-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04303039

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04303039, "Study to Investigate the Effects of Food on Relative Bioavailability of ABP-671 Tablets in Healthy Subjects". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04303039. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*